Cargando…
Clinical studies with MTA.
MTA (LY231514), a multi-targeted antifolate, is a classical antifolate undergoing intracellular polyglutamation. Polyglutamated MTA is a potent thymidylate synthase (TS) inhibitor and inhibits other folate-dependent enzymes, including dihydrofolate reductase and glycinamide ribonucleotide formyl tra...
Autores principales: | Calvert, A. H., Walling, J. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062802/ https://www.ncbi.nlm.nih.gov/pubmed/9717989 |
Ejemplares similares
-
Comparison of Rat Connective Tissue Response to BioMTA, Angelus MTA, and Root MTA
por: Alimohammadi, Marzieh, et al.
Publicado: (2021) -
Study of two MTA cements
por: Berástegui, Esther, et al.
Publicado: (2014) -
Comparison of Antibacterial Activities of ProRoot MTA, OrthoMTA, and RetroMTA Against Three Anaerobic Endodontic Bacteria
por: Khedmat, Sedigheh, et al.
Publicado: (2018) -
Deconvolution of the particle size distribution of ProRoot MTA and MTA Angelus
por: Ha, William Nguyen, et al.
Publicado: (2016) -
Evaluation of the cytotoxic effects of a new Harvard MTA compared to MTA Flow and ProRoot MTA on human gingival fibroblasts
por: Youssef, Abdel-Rahman, et al.
Publicado: (2021)